Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Acquired BRAF V600E Mutation Mediated Resistance to Osimertinib and Responded to Osimertinib, Dabrafenib, and Trametinib Combination Therapy
PaperCitations, authors & open-access status
Acquired BRAF V600E Mutation Mediated Resistance to Osimertinib and Responded to Osimertinib, Dabrafenib, and Trametinib Combination Therapy is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 40 citations, 2019 year and bronze oa status.
40
Citations
2019
Year
bronze
OA Status